Project Grant R43MH125549

Award Date 2/16/22
Completion Date 2/15/25
Dollars Obligated $919K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Small Business Innovation Research (SBIR) Phase I project award of $274,998 to Magnify Biosciences Inc. aims to develop an automated "AutoMagnify" device that physically expands biological specimens up to 1,000 times in 3D while preserving spatial and molecular integrity. This advancement will enable conventional light microscopes to achieve nanoscale imaging resolution capabilities...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) supports the development of a machine vision guided robotic system to automate the microinjection process for Drosophila melanogaster (fruit fly) embryos. The $294,543 award to Objective Biotechnology, Inc. will fund the evaluation and refinement of this automated microinjection technology across a range of experimental conditions and genetic backgrounds. Additionally,...
This $255,991 National Science Foundation project grant supports the development of an automated system for rapid analysis of biopsy samples by Amcyt, Inc. The system aims to increase the efficiency and accessibility of fine needle aspiration biopsy procedures through three automated processes: sample smearing, staining, and image capture. This addresses a critical need to improve biopsy analytics and potentially eliminate up to 20% of failed procedures due to sampling errors. By automating...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $337,326 to the University of Texas at Austin to develop computational microscopy technologies that can overcome the challenge of tissue scattering and achieve large-scale 3D imaging of tissue morphogenesis. The key objectives are to: (1) develop computational scattering models to reconstruct 3D refractive-index and fluorescent...
This Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of an automated imaging and analysis platform to study glial cell development in the mouse forebrain. The $538,523 award to North Carolina State University aims to: 1) optimize a pipeline for simultaneous and automated detection and classification of multiple...
This $1,521,607 Project Grant award from the National Institutes of Health's (NIH) Research Infrastructure Programs (CFDA 93.351) will provide Emory University with an automated robotic culture system to enhance the capabilities of their Organoid Hub. The Organoid Hub aims to standardize and scale the production of various organoid types, including brain, gut, cardiac, and kidney organoids, to facilitate advanced 3D cell culture research. The automated system will reduce hands-on time,...
The federal Project Grant award of $249,000 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) supports the development of a high-throughput photoacoustic histology platform for intraoperative pathological diagnosis. The project aims to create an ultrafast reflection-mode ultraviolet photoacoustic microscopy (UV-PAM) system using structured...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $994,138 to Modendo Inc., a for-profit company located in Boulder, CO, to develop and validate a prototype ultrathin endomicroscope instrument for high-resolution, minimally invasive optical imaging of the brain in animal neuroscience research. The key innovation is achieving a cross-sectional area more than 10 times smaller than...
This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, provides $349,171 to Cellchorus Inc. to develop an integrated computer vision system called LF-TIMING (Label-Free TIMING). The goal is to enable large-scale, label-free profiling of cell-cell interactions, particularly between immune cells and tumor cells. The LF-TIMING system will leverage deep neural networks to accurately analyze phase-contrast video recordings,...
This federal Project Grant award, valued at $681,287 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), is funding the development of a novel Light Pipe Microscope (LPM) system. The goal is to create an advanced two-photon fluorescence microscopy technology capable of high-resolution, wide-field cellular imaging across the entire...

CLEARBOT: A SYSTEM FOR FULLY AUTOMATED, HIGH-THROUGHPUT TISSUE CLEARING AND IMMUNOSTAINING - SUMMARY TISSUE CLEARING IS A POWERFUL TECHNIQUE THAT RENDERS LARGE BIOLOGICAL SAMPLES OPTICALLY TRANSPARENT AND ALLOWS 3D VISUALIZATION OF WIDE-BRAIN MOLECULAR ANATOMY. TO HELP DISSEMINATE THIS TECHNOLOGY, TRANSLUCENCE BIOSYSTEMS DEVELOPED A MESOSCALE IMAGING SYSTEM AND, USING PREVIOUS SBIR NIH SUPPORT, AN ANALYTICAL SOFTWARE PACKAGE FOR ADVANCED ANALYSIS OF BRAIN SAMPLES, 3TKTM. WHILE COMPLETE SOLUTIONS EXIST FOR IMAGING AND ANALYSIS OF CLEARED SAMPLES, NO COMPLETE SOLUTION EXISTS FOR THE HIGHLY LABOR INTENSIVE AND ERROR PRONE TISSUE CLEARING PROCESS. HERE TRANSLUCENCE BIOSYSTEMS INTRODUCE CLEARBOT, AN AUTOMATED SYSTEM FOR SAMPLE CLEARING AND IMMUNOSTAINING THAT WILL COMPLEMENT PREVIOUS TRANSLUCENCE DEVICES AND COMPLETE A PIPELINE FOR RELIABLE BRAIN- WIDE MOLECULAR ANATOMY OF INTACT RODENT AND HUMAN TISSUES. IN THIS PHASE I PROPOSAL, TRANSLUCENCE BIOSYSTEMS WILL BUILD A PROTOTYPE OF CLEARBOT AND DEMONSTRATE AUTOMATED BRAIN TISSUE CLEARING FOR WHOLE-BRAIN ANALYSIS. SPECIFIC AIMS: AIM 1: ASSEMBLE AND EVALUATE A CLEARBOT PROTOTYPE: THE BASIC FUNCTIONALITY OF THE PROTOTYPE DEVELOPED BY AN ENGINEERING CONSULTANT WILL BE EVALUATED FOR FUNCTIONALITY, ROBUSTNESS, ENERGY CONSUMPTION, AND OVERALL RELIABILITY. AIM 2: EVALUATE THE UTILITY OF CLEARBOT FOR AUTOMATED CLEARING AND IMMUNOSTAINING OF INTACT BRAINS: QUALITY AND REPEATABILITY OF TISSUE CLEARING WILL BE EVALUATED USING THE PROTOTYPE ASSEMBLED IN AIM 1. MULTIPLE MOUSE BRAINS WILL BE CLEARED AND IMMUNOSTAINED WITH CLEARBOT AND BENCHMARKED TO MANUAL PROCESSING DONE IN PARALLEL. THIS PHASE I PROJECT WILL DEMONSTRATE THE FEASIBILITY OF DEVELOPING AN AUTOMATED DEVICE THAT IS COMPARABLE TO OR BETTER THAN MANUAL CLEARING. FOLLOWING SUCCESS OF THIS PHASE I FEASIBILITY TESTING, FUTURE DEVELOPMENTS WILL ADVANCE THE PROTOTYPE TO A FLEXIBLE, COMMERCIAL-GRADE SYSTEM WITH A ROBUST AND SIMPLE USER-INTERFACE, HELPING RESEARCHERS APPLY THIS GAME-CHANGING TECHNOLOGY TO THEIR RESEARCH QUESTIONS.

Posted 2/16/22, 12:00 AM